Understand insulin pump benefits and drawbacks
If you take insulin for diabetes, you may have wondered whether an insulin pump could fit your lifestyle or help simplify certain parts of diabetes management. It's a common question, and one that doesn't have the same answer for everyone.
Many people successfully manage diabetes with multiple daily injections (MDI), while others prefer the flexibility and features a pump can offer. Each approach has advantages and trade-offs. This article explains how insulin pumps work, the potential benefits and drawbacks to consider, and how to decide whether pump therapy is worth discussing with your healthcare team.
Insulin pumps, defined
Insulin pumps are wearable devices designed to deliver insulin without the need for MDI. There are several types of insulin pumps available, including tubed and tubeless options, as well as automated and non-automated systems. Each offers a different approach to diabetes management, allowing people to choose the option that best fits their needs and preferences.
How an insulin pump works
Insulin pumps deliver insulin continuously, day and night. It mimics how a functioning pancreas releases insulin by providing a continuous background dose (called basal insulin) with the option to give extra doses at mealtimes (also known as bolus insulin). Most pumps can be programmed to match your individual insulin needs throughout the day. However, insulin pumps are just one method of insulin delivery, and many people continue to manage their diabetes using injections.
Basal insulin: continuous delivery in the background
Basal insulin helps manage glucose levels between meals and overnight. With MDI, basal insulin is typically provided through daily injections of long-acting insulin. With a pump, basal insulin is delivered continuously in small amounts via rapid-acting insulin throughout the day and night.
One potential advantage of pump therapy is the ability to adjust basal delivery at different times of day/night. This may be helpful for people whose insulin needs change throughout the day/night, such as those who experience dawn phenomenon, varying activity levels, or periods of increased insulin sensitivity.
With an automated system, known as Automated Insulin Delivery (AID) or a Hybrid Closed Loop (HCL) system, basal insulin is still delivered continuously in small amounts of rapid-acting insulin, just as it is with a standalone insulin pump. The difference is that the system uses continuous glucose readings to automatically adjust the basal insulin delivery rate throughout the day and night.
Bolus insulin: on-demand doses for meals and corrections
Bolus insulin helps cover carbohydrates in meals as well as correct high glucose levels. Many insulin pumps include a built-in calculator that can help estimate insulin doses using information such as carbohydrate intake, current glucose levels and trends.
Pumps can also deliver insulin in very small increments. For some people, particularly those who are highly sensitive to insulin, require relatively small doses, or experience hypoglycaemia unawareness, this level of dosing precision may offer additional flexibility compared with traditional injection methods.
The benefits of insulin pump therapy
The benefits below represent the advantages that some people experience with pump therapy. Remember that individual preferences, outcomes, and experiences vary.
Better blood glucose management
Insulin pumps can provide the ability to adjust insulin delivery throughout the day. Some people experience improvements in hbA1C and time in range when using insulin pump therapy.1 However, outcomes depend on many factors, including consistent device use, diabetes education, individual insulin needs, and overall treatment goals. Not everyone experiences the same results, and some people achieve similar outcomes using injection therapy.
Fewer needles and fewer injections
For many people, fewer needle sticks from injections are one of the most noticeable benefits of insulin pump therapy. Someone using MDI will take several insulin injections per day. Pump users generally replace an infusion set or Pod every few days while continuing to receive insulin throughout that time. For some people, reducing the number of daily needle sticks can help lessen treatment fatigue and make diabetes management feel more manageable.
More flexibility around meals, exercise, and daily life
Many pump users appreciate the ability to adjust insulin delivery based on what's happening in real time.
This may be helpful in situations such as:
- An unexpected workout
- A delayed or skipped meal
- Shift work or varying schedules
- Travel across time zones
- Changes in daily routines
For those interested in pump therapy, device design may also play a role. Some people prefer a traditional tubed system, while others prefer a tubeless option for activities such as exercise, sleep, or everyday wear.
Discreet, convenient insulin delivery
Insulin pumps allow users to deliver insulin without preparing a syringe or insulin pen every time a dose is needed.
Potential conveniences may include:
- Dosing without carrying injection supplies for each dose
- Delivering insulin more discreetly
- Accessing dose calculators
- Making insulin adjustments throughout the day
Potential quality of life improvements
Living with diabetes requires countless decisions each day. Some people report that pump features and less frequent needle sticks help reduce the effort involved in daily diabetes management. Research has shown improvements in treatment satisfaction and reductions in diabetes-related burden among some users of diabetes technologies.2
At the same time, others may find that wearing and maintaining a device introduces additional tasks and responsibilities. As with many aspects of diabetes management, quality of life benefits are highly personal and can vary significantly from one person to another.
Insulin pumps and CGMs: understanding how they work together
For people who choose pump therapy, additional benefits may be possible when the pump is paired with a continuous glucose monitor (CGM), sometimes simply known as a ‘sensor’.
Continuous glucose monitoring and insulin delivery
A CGM measures glucose levels throughout the day and night and provides ongoing glucose data. Some insulin pumps can use CGM information to help inform the system’s insulin delivery decisions and provide a more complete picture of glucose patterns than fingerstick checks alone.
Automated insulin delivery (AID) / Hybrid Closed Loop (HCL): the next step
AID systems combine an insulin pump, a compatible CGM, and software that automatically adjusts insulin delivery based on glucose readings. Potential benefits may include improvement in hbA1C levels, time in range, and other psychosocial benefits.1
However, users still need to remain engaged in their diabetes management and follow their healthcare team's recommendations.
Insulin pump trade-offs to consider
Every diabetes management approach has advantages and disadvantages. Understanding the possible challenges associated with pump therapy can help people decide whether it aligns with their individual needs, preferences, and goals.
Learning curve
Starting a pump requires learning new skills and routines. This may include:
- Understanding pump settings
- Changing infusion sites or Pods
- Troubleshooting alerts
- Managing insulin delivery during illness, exercise, and travel
Many people become comfortable with these tasks over time, but there is an adjustment period.
Wearing a device full-time
Pump therapy involves wearing a device continuously. Feelings about this can vary widely. Some hardly notice the device after a while, while others find wearing a device challenging.
Common considerations include:
- Comfort
- Visibility under clothing
- Sleeping with a device
- Sports and physical activity
- Body image preferences
Pump design, including whether a system is tubed or tubeless, may influence these experiences.
The risk of diabetic ketoacidosis (DKA) if the pump malfunctions
Because pumps typically use only rapid-acting insulin, interruptions in insulin delivery can cause glucose levels to rise relatively quickly. In some situations, this may increase the risk of DKA if a problem such as a site failure, blockage, or device malfunction goes unnoticed.
This risk can often be reduced through:
- Receiving proper training
- Checking pump sites routinely
- Tracking glucose levels with a CGM or blood glucose meter
- Following troubleshooting instructions
- Keeping backup insulin supplies available
People considering pump therapy should discuss this risk and appropriate backup plans with their healthcare team.
Who benefits most from insulin pump therapy?
While there’s no single profile of an ideal insulin pump user, some people may want to explore pump therapy because they:
- Experience frequent highs or lows
- Have varying insulin needs throughout the day
- Need very small insulin doses
- Are interested in CGM integration or automated insulin delivery
- Prefer fewer injections
Others may decide that injections work well for their lifestyle and treatment goals.
Your healthcare provider can help you determine which insulin therapy options are available to you and what may be most suitable, based on your clinical and lifestyle needs.
If you've previously ruled out pump therapy because you didn't want tubing, it's worth knowing that both tubed and tubeless options are available today. The best way to determine whether pump therapy makes sense for you is to have a conversation with your healthcare team about your goals, preferences, and treatment needs.
Learn more about the Omnipod® 5 Automated Insulin Delivery System
Pod Therapy with Omnipod 5 is a tubeless option designed to simplify insulin delivery without external tubing. Omnipod 5 pairs with a compatible continuous glucose monitor (CGM) to continuously deliver insulin and help keep glucose levels in range.3-4
Frequently asked questions
Do insulin pumps improve hbA1c levels?
Is an insulin pump better than an insulin pen?
Is it worth using an insulin pump?
Related Articles
Other topics
References and Disclaimers
1. American Diabetes Association Professional Practice Committee; 7. Diabetes Technology: Standards of Care in Diabetes—2026. Diabetes Care 1 January 2026; 49 (Supplement_1): S150–S165. https://doi.org/10.2337/dc26-S007
2. Miao, G., Saravanan, S., Munyombwe, T., Speight, J., Hill, A. J., Traviss-Turner, G., Ajjan, R. A. (2025). Effects of Modern Glucose Monitoring and Insulin Delivery Technologies on Patient-Reported Outcomes and Experiences in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis. Diabetes Care, 48(12), 2160–2180. https://doi.org/10.2337/dc25-1178
3. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in range for standard therapy vs Omnipod 5 in adults/adolescents and children = 64.7% vs. 73.9%; 52.5% vs. 68.0%. Study funded by Insulet.
4. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in range for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Study funded by Insulet.
The information provided is not intended as a substitute for professional medical advice. Individual symptoms, situations, and circumstances may vary. Please consult your Healthcare Professional regarding your condition and appropriate medical treatment.
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin.
The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM). When in automated mode, the Omnipod 5 system is designed to assist people with type 1 diabetes in achieving glycaemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or pause) insulin delivery to operate within predefined threshold values using current and predicted CGM values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycaemia and hypoglycaemia.
The Omnipod 5 System can also operate in a manual mode that delivers insulin at set or manually adjusted rates.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.